Press Releases


Latest News


Adamas Reports Third Quarter 2014 Financial Results
Nov 4, 2014 | Financial Releases

Adamas Pharmaceuticals Expands Its Phase 3 Program With ADS-5102 for the Treatment of Levodopa-induced Dyskinesia (LID) in Patients With Parkinson's Disease
Oct 28, 2014 | General Releases

Adamas Pharmaceuticals Announces Management Changes
Aug 13, 2014 | General Releases

Adamas Reports Second Quarter 2014 Financial Results
Aug 7, 2014 | Financial Releases

United States Patent Issued to Adamas Pharmaceuticals
Aug 5, 2014 | General Releases

Adamas Pharmaceuticals To Present At JMP Securities Healthcare Conference 2014
Jun 16, 2014 | General Releases

Adamas Pharmaceuticals Announces Rater Training Data on ADS-5102 for Parkinson's Disease Patients with Levodopa-Induced Dyskinesia
Jun 10, 2014 | General Releases

Adamas Pharmaceuticals Initiates Phase 3 Trial For ADS-5102 In Parkinson's Disease Patients With Levodopa-Induced Dyskinesia
Jun 9, 2014 | General Releases

United States Patent Issued To Adamas Pharmaceuticals
Jun 9, 2014 | General Releases

Adamas Pharmaceuticals Announces Data Update At The International Congress Of Parkinson's Disease And Movement Disorders
May 29, 2014 | General Releases

Pages:  1 2 3 4 5 6 7 8 9 10 11 12